Search
for
Sort by
Research 181–210 of 1000+
- Diagnosis and management of pemphigus foliaceus in a dog
- Comparison of clinical characteristics among different time of disease onset in patients with systemic lupus erythematosus patients
- Acute Disseminated Paracoccidioidomycosis with Molluscoid Lesions in a Young Woman
- Clinical Application of Renshen Yangrong Tang
- Telogeen effluvium
- Telogeen effluvium
- [A systemic-like disease: chronic vitamin A poisoning].
- A case of systemic lupus erythematosus complicated with aortic regurgitation due to bacterial endocarditis
- A Case of Systemic Lupus Erythematosus with Cutaneous Leukocytoclastic Vasculitis
- Pharmacological Efficacy of Tamarix aphylla: A Comprehensive Review
- <i>Ziziphus</i>: A prospective multi application fruit tree
- Cytokines
- Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
- A Review on Calotropis Gigantea Latex Used in Skin Conditions
- Miscellaneous Skin Diseases
- Ziziphus spina-christi (Christ’s Thorn Jujube)
- Managing hair loss
- Late-Onset Systemic Lupus Erythematosus
- Cutaneous signs in COVID ‐19 patients: A review
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Clinical and immunological manifestations in 151 SLE patients living in Dubai
- The spectrum of inflammatory skin disease following jejuno-ileal bypass for morbid obesity
- Pattern of systemic lupus erythematosus among Nigerians
- Chemotherapy for children with medulloblastoma
- Six-year Retrospective Review of Drug Reaction with Eosinophilia and Systemic Symptoms
- Toxic shock syndrome: Recent developments in pathogenesis
- Systemic lupus erythematosus (SLE) in the eastern region of Saudi Arabia. A comparative study
- Hair loss in children: Common and uncommon causes; clinical and epidemiological study in Jordan
- Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata – part II
- Incidence and management of cutaneous toxicities associated with cetuximab